Market Overview:
The global oral rotavirus vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of rotavirus infections, rising demand for pediatric vaccines, and growing investments by key players in research and development (R&D) activities. Based on type, the global oral rotavirus vaccine market can be segmented into Rotarix, RotaTeq, Rotavac, Rotavin-M1, and Lanzhou lamb. Of these types, Rotarix is expected to account for the largest share of the global oral rotavirus vaccine market during the forecast period. This can be attributed to its high efficacy and safety profile as well as its large product portfolio. Based on application, hospital accounted for the largest share of the global oral rotavirus vaccine market in 2017. This can be attributed to rising demand for pediatric vaccines from hospitals across regions owing to increasing awareness about their benefits among parents/guardians.
Product Definition:
An oral rotavirus vaccine is a vaccine that is given orally (by mouth). It protects against rotavirus, a virus that can cause severe diarrhea.
Rotarix:
Rotarix is a vaccine against rotavirus. It is developed by GlaxoSmithKline Biologicals and was approved in Europe in 2006 and 2007 for the prevention of gastro-intestinal diseases, including Rotarix-related diarrhea among children below five years of age. The vaccine has been licensed by GSK for use in more than 50 countries across the globe, with India being one of them.
RotaTeq:
RotaTeq is a non-adjuvanted oral vaccine against rotavirus. It is manufactured by Merck & Co., Inc. and was approved in 2015 for use in the U.S and 2016 for use across Europe, Australia, Latin America, and some Asian countries including Japan.
Application Insights:
Based on the application, the global oral rotavirus vaccine market is segmented into hospital, vaccination station, and others. Hospital was estimated as the largest application segment in 2017 owing to growing awareness about immunization against Rotarix, RotaTeq and other brands of oral vaccines. Growing number of hospitals with immunization stations for children under 5 years old also supported in major part towards larger share of this segment. Other applications include travel clinics and private practices.
Rising incidences associated with immunity against only one strain ofRotavirus has created a need for new vaccines that offer protection against different strains as well as a broader spectrum of infection which includes both G1 & G2 viruses globally since 2012 when RotaTeq was approved by U.
Regional Analysis:
Europe dominated the global market in 2017 owing to high demand for new rotavirus vaccines and presence of a large number of players. The European Commission has approved two rotavirus vaccine candidates, RotaTeq (Trumenba) and Rotarix (RVX-1473), for marketing. These factors are expected to boost the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to increasing awareness about vaccination programs among children, parents, and healthcare providers in this region. Furthermore, growing target population base along with rising incidence rate of severe diarrhea caused by rotavirus infection is also expected drive regional growth over the next eight years.
Growth Factors:
- Increasing incidence of rotavirus infection in children across the globe
- Rising demand for oral rotavirus vaccine due to its safety and efficacy
- Growing awareness about the benefits of oral rotavirus vaccine among parents and healthcare professionals
- Technological advancements in oral rotavirus vaccine manufacturing process
- increasing government initiatives to promote vaccination against rotavirus infection
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Rotavirus Vaccine Market Research Report
By Type
Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb
By Application
Hospital, Vaccination Station, Other
By Companies
GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Oral Rotavirus Vaccine Market Report Segments:
The global Oral Rotavirus Vaccine market is segmented on the basis of:
Types
Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Vaccination Station, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Sanofi-Pasteur
- Merck
- Biological E. Limited
- China National Biotec Group
- Sinovac Biotech
Highlights of The Oral Rotavirus Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rotarix
- RotaTeq
- Rotavac
- Rotavin-M1
- Lanzhou lamb
- By Application:
- Hospital
- Vaccination Station
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Rotavirus Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral rotavirus vaccine is a vaccine that helps protect against rotavirus, a virus that can cause severe diarrhea in infants and young children. Oral rotavirus vaccine is given as a shot to children aged 2 months through 6 years. It is also available as an oral drops for older children and adults.
Some of the key players operating in the oral rotavirus vaccine market are GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Rotavirus Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Rotavirus Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Rotavirus Vaccine Market - Supply Chain
4.5. Global Oral Rotavirus Vaccine Market Forecast
4.5.1. Oral Rotavirus Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Rotavirus Vaccine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Rotavirus Vaccine Market Absolute $ Opportunity
5. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
5.3.1. Rotarix
5.3.2. RotaTeq
5.3.3. Rotavac
5.3.4. Rotavin-M1
5.3.5. Lanzhou lamb
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Vaccination Station
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Rotavirus Vaccine Demand Share Forecast, 2019-2026
9. North America Oral Rotavirus Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Vaccination Station
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
9.7.1. Rotarix
9.7.2. RotaTeq
9.7.3. Rotavac
9.7.4. Rotavin-M1
9.7.5. Lanzhou lamb
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Rotavirus Vaccine Demand Share Forecast, 2019-2026
10. Latin America Oral Rotavirus Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Vaccination Station
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
10.7.1. Rotarix
10.7.2. RotaTeq
10.7.3. Rotavac
10.7.4. Rotavin-M1
10.7.5. Lanzhou lamb
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Rotavirus Vaccine Demand Share Forecast, 2019-2026
11. Europe Oral Rotavirus Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Vaccination Station
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
11.7.1. Rotarix
11.7.2. RotaTeq
11.7.3. Rotavac
11.7.4. Rotavin-M1
11.7.5. Lanzhou lamb
11.8. Basis Point Share (BPS)Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Rotavirus Vaccine Demand Share, 2019-2026
12. Asia Pacific Oral Rotavirus Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Vaccination Station
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
12.7.1. Rotarix
12.7.2. RotaTeq
12.7.3. Rotavac
12.7.4. Rotavin-M1
12.7.5. Lanzhou lamb
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Rotavirus Vaccine Demand Share, 2019-2026
13. Middle East & Africa Oral Rotavirus Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Vaccination Station
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
13.7.1. Rotarix
13.7.2. RotaTeq
13.7.3. Rotavac
13.7.4. Rotavin-M1
13.7.5. Lanzhou lamb
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Rotavirus Vaccine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Rotavirus Vaccine Market: Market Share Analysis
14.2. Oral Rotavirus Vaccine Distributors and Customers
14.3. Oral Rotavirus Vaccine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi-Pasteur
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biological E. Limited
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. China National Biotec Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sinovac Biotech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook